⚠️ RESEARCH USE ONLY — NOT FOR HUMAN CONSUMPTION🔬 JANOSHIK VERIFIED — 99.38% purity. Full COA with every order.🇬🇧 UK STOCK — buyalluvi.co.uk · Official Site.⚠️ RESEARCH USE ONLY — NOT FOR HUMAN CONSUMPTION🔬 JANOSHIK VERIFIED — 99.38% purity. Full COA with every order.🇬🇧 UK STOCK — buyalluvi.co.uk · Official Site.
← Back to Research Blog
Research Guide

Retatrutide 20mg vs 40mg Pen — Which Should You Choose for Research?

Alluvi Healthcare UKApril 2026Research Use Only
Retatrutide 20mg vs 40mg Pen — Which Should You Choose for Research?

Alluvi Healthcare supplies retatrutide in two pen formats — the 20mg and the 40mg pre-filled research device. Choosing between them depends on your research protocol, dose-response objectives, and the phase of investigation. This guide covers the differences in detail.

Research Use OnlyAll information is for in vitro laboratory research context only. Not for human or veterinary consumption.

Format Overview

SpecRetatrutide 20mg PenRetatrutide 40mg Pen
Total peptide per pen20mg40mg
Doses per pen4 doses of 5mg4 doses of 10mg
FormatPre-filled, ready to usePre-filled, ready to use
BatchAR0763RT4AR0763RT4
Purity99.38% HPLC99.38% HPLC
Single price£125£195
COA includedYes — JanoshikYes — Janoshik

When to Use the 20mg Pen

Titration Research

The 20mg pen (4 × 5mg doses) is ideal for dose-escalation titration studies, where starting at lower concentrations and incrementally increasing allows researchers to document threshold responses, receptor saturation curves and dose-dependent efficacy patterns. The 5mg dose increment provides finer control for these protocols.

Dose-Response Studies

If your research objective is to establish dose-response relationships — mapping receptor activity across a range of concentrations — the 20mg pen provides the lower end of the concentration range needed for a complete dose-response curve when paired with the 40mg format.

Extended Low-Dose Protocols

For extended research protocols requiring sustained lower-concentration exposure over time, the 20mg pen or the x2 bundle (£169.99) provides more doses per unit cost at the 5mg level.

When to Use the 40mg Pen

High-Dose Mechanism Studies

The 40mg pen (4 × 10mg doses) is suited to research focused on maximal receptor agonism — understanding the ceiling effect, tri-receptor saturation (GLP-1/GIP/Glucagon) and peak metabolic modulation. Phase 2 clinical data used 12mg weekly as the highest dose in human studies, making the 10mg research dose relevant to this investigation range.

Comparative Compound Studies

When comparing retatrutide against tirzepatide or semaglutide in parallel research protocols, the 40mg pen's higher dose range enables equivalent or higher receptor engagement for direct mechanistic comparison.

Can You Use Both Together?

Yes — many research programmes use both formats. A common approach is to begin dose-escalation with the 20mg pen and progress to the 40mg format once lower-dose response is established. The Retatrutide 40mg x2 Bundle (£320) and 20mg x2 Bundle (£169.99) are designed for exactly this kind of extended protocol.

Which Offers Better Value?

FormatPricePer mg
Retatrutide 20mg single£125£6.25/mg
Retatrutide 20mg x2 Bundle£169.99£4.25/mg
Retatrutide 40mg single£195£4.88/mg
Retatrutide 40mg 3-pack£510£4.25/mg
Retatrutide 40mg 10-pack£1,500£3.75/mg

The 40mg format offers better value per milligram at all quantity levels. The 20mg pen's advantage is the smaller dose increment — 5mg vs 10mg — which is specifically useful for titration and precision dose-response protocols.

Buy Research-Grade Retatrutide UK

Alluvi Healthcare supplies independently verified research peptides with full COA, cold chain delivery and UK-based support. Batch AR0763RT4 — 99.38% purity.

Chat with us